Activity assay of vascular endothelial growth factor in prokaryocytes
Yao-zhen Lei,Pei Yang,Kun-zheng Wang,Zhi-bin Shi,Jian-long Ni,Peng-bo Yu,Xiao-qian Dang,Chun-sheng Wang,Fu-liang Gong
DOI: https://doi.org/10.3321/j.issn:1673-8225.2008.42.001
2008-01-01
Abstract:Background: The vascular endothelial growth factor used in clinic is restricted by limited resources and difficulty in preparation. Objective: To culture and isolate the human vascular endothelial growth factor (hVEGF165) by genetic engineering method in escherichia coli, test the biological activity and immunologic competence in order to offer proteinum for the construction of tissue engineered bone. Design, time and setting: The open experiment of single sample observation was performed at the Laboratory of Virus of Shaanxi Provincial Center for Disease Control and Prevention between April 2005 and January 2007. Materials: The cloning vector PUC18-VEGF165 was constructed by Shi Zhi-bin, a doctor from Second Affiliated Hospital of Xi'an Jiaotong University, the plasmid PGEM-T easy was produced by Promerga Company of USA, prokaryotic expression plasmid was purchased from Qiagen Company of Germany, DH5a, M15, JM109 strains were conserved by Shanaxi Provincial Center for Disease Control and Prevention. Methods: The objective gene fragment was subcloned by polymerase chain reaction, and then it was inserted into pQE30 plasmid. IPTG was used in escherichia coli Jm109 and purified by Ni21-NTA to gain hVEGF165 fusion protein. Main outcome measures: Subclone of hVEGF165, identification of recombinant expression vector pQE30-hVEGF165, induced expression of hVEGF165 were observed in the study. Immunologic competence and biological activity were detected by ELISA, Western blot, HET-CAM and matrigel angiogenesis assay, respectively. Results: The recombinant hVEGF165 fusion protein with relative molecular mass 23 000 was successfully expressed in escherichia coli Jm 109 as an inclusion body, and accounted for 30% of total cellular protein. Western blot, ELISA, HET-CAM and matrigel angiogenesis assay showed that purified protein had an excellent immunologic competence and biological activity. Conclusion: The recombinant hVEGF165 with excellent biological activity is successfully expressed in escherichia coli Jm109 and offer sufficient proteinum for the construction of prefabricated tissue engineered bone.